We are delighted to announce that SinoMedCare BioTech Co., Ltd. (SMC) has become the exclusive distributor of our vibrating mesh nebulizer Pulmogine in China.

HCmed is ready to join the fight. Our mesh nebulizers are highly efficient customizable devices that deliver drugs deep into the lungs.

HCmed Innovations is pleased to inform that it has received NMPA approval from the National Medical Products Administration in China for its handheld mesh nebulizer, Pulmogine.

Aiming to continue expanding its global presence and promoting its new brand “Pulmogine,” HCmed Innovations participated at two main events held in China this month.

HCmed Innovations Co., Ltd., presented its latest brand, Pulmogine, in the 2019 ERS International Congress.

HCmed Innovations Co., Ltd. (HCmed) has been selected as the first batch companies to join Wuxi International Life Science Innovation Park.

HCmed Innovations Co., Ltd., in collaboration with one of the world's top 10 pharmaceutical companies, has officially launched its vibrating mesh nebulizer, Deepro, in the Federative Republic of Brazil.

HCmed Innovations (HCmed) confirmed on December 27, 2017, that Vivo capital, through the fund under its management, PANDA Fund, L.P., has become its strategic investor.

Deepro is ready to blow your mind by its incredibly chic look and superior performance!